Mustang Bio
MBIO
55 hedge funds and large institutions have $40.1M invested in Mustang Bio in 2019 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 22 increasing their positions, 3 reducing their positions, and 2 closing their positions.
1,000% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 2
633% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 3
382% more capital invested
Capital invested by funds: $8.31M → $40.1M (+$31.7M)
49% more funds holding
Funds holding: 37 → 55 (+18)
0.02% more ownership
Funds ownership: 0.01% → 0.04% (+0.02%)
39% less call options, than puts
Call options by funds: $235K | Put options by funds: $387K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
+$12.8M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.62M |
| 3 |
BlackRock
New York
|
+$3.57M |
| 4 |
6CM
683 Capital Management
New York
|
+$2.38M |
| 5 |
Renaissance Technologies
New York
|
+$1.71M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$74K |
| 2 |
FAM
Fenimore Asset Management
Cobleskill,
New York
|
-$31.4K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$11.4K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$7K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$5.71K |
MBIO Hedge Fund Activity: Q2 2019 in Review
55 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Mustang Bio (MBIO) for Q2 2019, worth a combined $40.1M — up 382% from $8.31M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new MBIO positions and 2 closed out — a net gain of 20 holders — while 22 added to existing stakes and 3 trimmed.
The largest buyer was Consonance Capital Management, opening a new position worth an estimated $12.8M. The largest seller was State of Wisconsin Investment Board, exiting entirely with an estimated $74K sold.
- 55 institutional investors held Mustang Bio (MBIO) as of Q2 2019, up from 37 in Q1 2019.
- Funds reported $40.1M of Mustang Bio stock for Q2 2019, up 382% quarter-over-quarter.
- 22 funds opened new Mustang Bio positions in Q2 2019 and 2 closed out, a net change of +20 holders.
- The largest Mustang Bio buyer in Q2 2019 was Consonance Capital Management, an estimated $12.8M added.
- The largest Mustang Bio seller in Q2 2019 was State of Wisconsin Investment Board, an estimated $74K sold.
Based on aggregated 13F filings for Q2 2019.